Isofol Medical AB (publ) appoints Carnegie Investment Bank AB (publ) to Financial advisor
GOTHENBURG, Sweden, February 27, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), announced today that the company and the board have appointed Carnegie Investment Bank AB (publ) as financial advisor to explore a possible listing of the company's shares at Nasdaq Stockholm main market within 12-18 months and to evaluate other strategic and financial initiatives together with Pareto Securities AB.For further information, please contact: Isofol Medical AB (publ)Anders Rabbe, CEOE-mail: info@isofolmedical.comPhone: +46 (0)707 646 500 Gustaf Albert, CFOE-